Skip to main content
. 2018 Jan 22;2018(1):CD012788. doi: 10.1002/14651858.CD012788.pub2

NCT01502280 (BALANCE).

Study name Fluorescence‐guided surgery for low‐ and high‐grade gliomas
Methods Randomised. Single‐blind
Participants Newly diagnosed glioma (high and low grade)
Interventions 5‐ALA (Gliolan) versus placebo (ascorbic acid)
Outcomes
  1. Volume of residual disease

  2. Overall survival

  3. 6‐month progression‐free survival

Starting date November 2010
Contact information Nader Sanai (principal investigator), Norissa Honea (overall contact)
Notes Barrow, Phoenix, Arizona, USA